Citadel Advisors
ANGO icon

Citadel Advisors’s AngioDynamics ANGO Stock Holding History

Citadel Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,700
Closed -$190K – 13632
2026
Q1 		$190K Buy
16,700
+3,200
+24% +$34.7K ﹤0.01% 11465
2025
Q4 		$173K Sell
13,500
-17,700
-57% -$218K ﹤0.01% 11165
2025
Q3 		$349K Buy
31,200
+10,500
+51% +$101K ﹤0.01% 10013
2025
Q2 		$205K Buy
20,700
+1,800
+10% +$17.6K ﹤0.01% 10630
2025
Q1 		$177K Buy
18,900
+6,900
+58% +$72.5K ﹤0.01% 10620
2024
Q4 		$110K Buy
12,000
+3,100
+35% +$22.8K ﹤0.01% 11344
2024
Q3 		$69.2K Buy
8,900
+5,800
+187% +$41.9K ﹤0.01% 11574
2024
Q2 		$18.8K Sell
3,100
-200
-6% -$1.23K ﹤0.01% 12699
2024
Q1 		$19.4K Buy
3,300
+700
+27% +$4.16K ﹤0.01% 13037
2023
Q4 		$20.4K Buy
2,600
+1,900
+271% +$13.2K ﹤0.01% 12604
2023
Q3 		$5.12K Sell
700
-1,000
-59% -$8.32K ﹤0.01% 13419
2023
Q2 		$17.7K Sell
1,700
-4,300
-72% -$41.4K ﹤0.01% 12839
2023
Q1 		$62K Buy
6,000
+5,500
+1,100% +$70.4K ﹤0.01% 11882
2022
Q4 		$6.88K Buy
+500
New +$6.96K ﹤0.01% 13874
2022
Q1 		– Sell
-7,800
Closed -$215K – 13498
2021
Q4 		$215K Sell
7,800
-1,100
-12% -$30.4K ﹤0.01% 11690
2021
Q3 		$231K Buy
+8,900
New +$238K ﹤0.01% 11660
2021
Q2 		– Sell
-10,200
Closed -$239K – 13606
2021
Q1 		$239K Buy
+10,200
New +$206K ﹤0.01% 11336
2020
Q4 		– Sell
-11,400
Closed -$137K – 10867
2020
Q3 		$137K Buy
+11,400
New +$108K ﹤0.01% 9067
2019
Q2 		– Sell
-10,400
Closed -$238K – 9119
2019
Q1 		$238K Buy
+10,400
New +$226K ﹤0.01% 7946
2016
Q4 		– Sell
-12,500
Closed -$219K – 7206
2016
Q3 		$219K Buy
+12,500
New +$203K ﹤0.01% 6180

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's ANGO Position: Q2 2026 in Review

Citadel Advisors reduced its AngioDynamics (ANGO) stake by 74% in Q2 2026, selling an estimated $408K and leaving 12,484 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #12274.

Citadel Advisors first reported a position in ANGO in Q1 2014 and has held it in 42 quarters since. The position peaked at $7.95M in Q4 2023. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Citadel Advisors held 12,484 shares of AngioDynamics worth $162K as of Q2 2026.
  • Citadel Advisors sold 35,838 AngioDynamics shares in Q2 2026, an estimated $408K.
  • AngioDynamics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12274 holding.
  • Citadel Advisors first reported a position in AngioDynamics in Q1 2014 and has held it in 42 quarters since.
  • Citadel Advisors's AngioDynamics position peaked at $7.95M in Q4 2023.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.